QUMEA Secures CHF 9m in Series A Funding
The Swiss digital health company QUMEA raises CHF 9 million in its Series A financing round. QUMEA specializes in intelligent early warning systems for healthcare providers. The funds mark a significant milestone in the progression of QUMEA's long-term strategy. The...
QUMEA at the Hirslanden Klinik im Park!
QUMEA now supports various departments at Hirslanden Klinik im Park: in Cardiology & Cardiac Surgery, as well as in the Department of Interdisciplinary Surgery and Visceral Surgery, Orthopaedics and Urology. "We are driving innovation to ensure that our patients...
QUMEA sides with Södertälje Hospital to boost fall prevention
Södertälje Hospital is pioneering the use of Artificial Intelligence (AI) monitoring systems to significantly decrease patient falls within its wards. Nursing assistant Håkan Bertnor sees this as the future of patient care, noting a decline in falls and enhanced...
QUMEA helps two Swedish hospitals to reduce their fall rate by 67%
QUMEAs AI-based technology is currently used successfully in several European countries and has now been tested in Sweden in 2023. Results from Sahlgrenska University Hospital and Södra Älvsborg Hospital show a 67% reduction in the number of falls. QUMEA was installed...
Innovative Integration: Alterszentrum zur Rose Implements QUMEA with SmartLiberty
The Alterszentrum zur Rose has integrated QUMEA into the recently introduced SmartLiberty system. This marks a milestone as our first fully implemented project in collaboration with our partner SmartLiberty. QUMEA is seamlessly integrated into SmartLiberty's motica...
QUMEA receives the SEF.Growth High Potential Label
SEF.Growth, the startup program of the Swiss Economic Forum, evaluates up to 80 startups annually, with around 25% of them receiving the SEF.Growth High Potential Label, which acknowledges their strong strategy and outstanding growth potential. This label also serves...
Regulatory Statement & Conformity
MDR Statement
QUMEA Care is not a medical device according to Regulation (EU) 2017/745 and therefore does not fall within its scope of the same.
QUMEA Care is intended for the prevention of injuries. According to Article 2 paragraph 1 of Regulation (EU) 2017/745 (European Union Medical Device Regulation - MDR), the prevention of an injury is not a medical purpose. The movement and activity data as recorded and displayed by QUMEA Care are ultimately intended to be used to prevent injuries. The device is not intended to be used for "diagnosis, monitoring, treatment, alleviation of, or compensation for, an injury" and accordingly, not for a specific medical purpose.
QUMEA Mobility Sense is a Class 1 medical device according to Regulations (EU) 2017/745 (European Union Medical Device Regulation - MDR) and MepV (2020/812.213).
QUMEA Mobility Sense is intended to be used for prevention of Decubitus ulcers and pressure areas (ICD L89). The product is solely used to inform the caretaker when a patient did not show a certain level of mobilization for a specific amount of time. The required level of mobilization is defined as a change in posture of the recumbent subject (e.g. turning from supine to lateral position). No diagnostic or therapeutic decisions can be made based on the output of the data.
Conformity (CE)
QUMEA sensor products are in conformity with European health, safety, and environmental protection standards.
QUMEA AG CHRN: CHRN-MF-20002870
Classification and conformity documentation, as well as additional documents, are available upon request from QUMEA AG.
Impressum
Verantwortlich für den Inhalt:
QUMEA AG
Westbahnhofstrasse 3
CH-4500 Solothurn
+41 (0)32 525 60 50
info@qumea.com
UID: CHE-439.197.016
Rechtsform: Aktiengesellschaft
Kontaktperson:
Cyrill Gyger
Bitte beachten Sie auch die Datenschutzerklärung von QUMEA.
Diese Seite ist durch reCAPTCHA geschützt und es gelten die Datenschutzerklärung sowie die Nutzungsbedingungen von Google.
Bilder unter Lizenz von kandis-fotografie.ch, QUMEA AG, Shutterstock.com.
Demo anfordern
Wir freuen uns sehr, dass Sie QUMEA in Aktion sehen wollen. Bitte hinterlassen Sie uns ein paar Angaben und wir werden uns umgehend mit Ihnen in Verbindung setzen, um eine Demo mit Ihnen zu vereinbaren.